London, Canada, May 20, 2010 --(PR.com
)-- Christie Hospital located in Manchester, United Kingdom, is one of Europe’s leading cancer centers, treating over 40,000 patients a year and is an acknowledged leader in international research. The prostate cancer brachytherapy program is the largest in the U.K and has just treated its 1,000th patient using iodine-125 permanent brachytherapy implants.
Cooperation between Christie Hospital and the IBt Bebig group dates back to 2006. Dr. James Wylie, Radiation Oncologist, commented: “Our excellent working relationship with IBt Bebig has greatly facilitated this cancer treatment program and we now plan to be collaborating with IBt Bebig on the development of new products.”
The brachytherapy treatment of early state prostate cancer is being applied increasingly across the continent, where more than 135,000 new case of prostate cancer are diagnosed every year. Of this number, just over 12,000 men are treated with permanent brachytherapy implants.
IBt Bebig is represented in Canada by CSP Medical, a company highly experienced in every area of source technology and its associated applications.
CSP Medical offers cost efficient and complete brachytherapy solutions in the areas of: prostate seed implantation, Ophthalmic brachytherapy, HDR afterloading, Treatment planning software and Therapy accessories.
For more information, visit www.cspmedical.com
For Media inquiries:
Leela Sharma, Marketing & Communications firstname.lastname@example.org 800.265.3460 ext 33